Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Avacopan
1.2.3 Immune Globulin
1.2.4 Rituximab Biosimilar
1.2.5 Others
1.3 Market by Application
1.3.1 Global Microscopic Polyangiitis (MPA) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Perspective (2019-2030)
2.2 Microscopic Polyangiitis (MPA) Treatment Growth Trends by Region
2.2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microscopic Polyangiitis (MPA) Treatment Historic Market Size by Region (2019-2024)
2.2.3 Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Region (2025-2030)
2.3 Microscopic Polyangiitis (MPA) Treatment Market Dynamics
2.3.1 Microscopic Polyangiitis (MPA) Treatment Industry Trends
2.3.2 Microscopic Polyangiitis (MPA) Treatment Market Drivers
2.3.3 Microscopic Polyangiitis (MPA) Treatment Market Challenges
2.3.4 Microscopic Polyangiitis (MPA) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Revenue
3.1.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Revenue (2019-2024)
3.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microscopic Polyangiitis (MPA) Treatment Revenue
3.4 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio
3.4.1 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microscopic Polyangiitis (MPA) Treatment Revenue in 2023
3.5 Microscopic Polyangiitis (MPA) Treatment Key Players Head office and Area Served
3.6 Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service
3.7 Date of Enter into Microscopic Polyangiitis (MPA) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microscopic Polyangiitis (MPA) Treatment Breakdown Data by Type
4.1 Global Microscopic Polyangiitis (MPA) Treatment Historic Market Size by Type (2019-2024)
4.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Type (2025-2030)
5 Microscopic Polyangiitis (MPA) Treatment Breakdown Data by Application
5.1 Global Microscopic Polyangiitis (MPA) Treatment Historic Market Size by Application (2019-2024)
5.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Microscopic Polyangiitis (MPA) Treatment Market Size (2019-2030)
6.2 North America Microscopic Polyangiitis (MPA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2019-2024)
6.4 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microscopic Polyangiitis (MPA) Treatment Market Size (2019-2030)
7.2 Europe Microscopic Polyangiitis (MPA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2019-2024)
7.4 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Size (2019-2030)
8.2 Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microscopic Polyangiitis (MPA) Treatment Market Size (2019-2030)
9.2 Latin America Microscopic Polyangiitis (MPA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2019-2024)
9.4 Latin America Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Market Size (2019-2030)
10.2 Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Celltrion Inc
11.1.1 Celltrion Inc Company Detail
11.1.2 Celltrion Inc Business Overview
11.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Introduction
11.1.4 Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2019-2024)
11.1.5 Celltrion Inc Recent Development
11.2 ChemoCentryx Inc
11.2.1 ChemoCentryx Inc Company Detail
11.2.2 ChemoCentryx Inc Business Overview
11.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Introduction
11.2.4 ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2019-2024)
11.2.5 ChemoCentryx Inc Recent Development
11.3 Sandoz International GmbH
11.3.1 Sandoz International GmbH Company Detail
11.3.2 Sandoz International GmbH Business Overview
11.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Introduction
11.3.4 Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2019-2024)
11.3.5 Sandoz International GmbH Recent Development
11.4 Teijin Pharma Ltd
11.4.1 Teijin Pharma Ltd Company Detail
11.4.2 Teijin Pharma Ltd Business Overview
11.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
11.4.4 Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2019-2024)
11.4.5 Teijin Pharma Ltd Recent Development
11.5 TTY Biopharm Company Ltd
11.5.1 TTY Biopharm Company Ltd Company Detail
11.5.2 TTY Biopharm Company Ltd Business Overview
11.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
11.5.4 TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2019-2024)
11.5.5 TTY Biopharm Company Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details